PridCor Therapeutics, LLC

TUSCALOOSA, AL · Founded 2025 · CIK 0002074593 · Biotech · Private

Therapeutics targeting post-viral syndromes and associated conditions

pridcor.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$6.0M
3 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$40,000
Private capital raisedForm D · SEC$1,000,000
Private capital raisedForm D · SEC$6,045,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1459ArTara Therapeutics, Inc.—$4.2M
1460REVIVBIO, INC—$3.1M
1461Cage Bio, Inc.—$19M
1462PridCor Therapeutics, LLC—$6.0M
1463BLUESTEM BIOSCIENCES INC—$5.0M
1464Lapix Therapeutics Inc.—$12M
1465ANDSON BIOTECH INC.—$8.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Brian CordayExecutive Officer · Promoter
  • William PridgenExecutive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.